Improving Mechanical Properties of Carboxyl-Terminated Polybutadiene (CTPB) Binder System Using a Cure Accelerator

  • Xiao Qu
  • , Peixuan Hu
  • , Xinyi Ma
  • , Yunfei Liu
  • , Hongtao Yang
  • , Wei Zhang*
  • , Yu Chen*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

To address the issues of slow curing rate, post-curing reactions, and suboptimal mechanical properties in the carboxyl-terminated polybutadiene (CTPB)/epoxy resin (EP) binder system used for solid propellants, this study optimized the curing system by introducing 593 aliphatic amine compounds containing primary and secondary amine groups as a cure accelerator. It is found that the incorporation of the cure accelerator improved the fracture strength and elongation at break of the CTPB/EP binder system. With the addition of 0.3 wt.% cure accelerator, the tensile fracture strength increased to 0.37 MPa, while the elongation at break reached 655%. Moreover, augmenting the quantity of cure accelerator can substantially elevate the crosslink density and gel fraction of the binder system. When the addition reaches 0.3 wt.%, the crosslink density is 4.3 × 10−4 mol/cm3. Further studies showed that 593 cure accelerator reduced the activation energy of the curing reaction of the CTPB/EP binder system, with higher levels of cure accelerator resulting in lower activation energy. This study established a preparation methodology for a CTPB/EP binder system with high elongation and tensile strength. These findings provide a solid scientific foundation for the application of CTPB-based binder systems in solid propellants.

Original languageEnglish
Article number284
JournalMolecules
Volume31
Issue number2
DOIs
Publication statusPublished - Jan 2026

Keywords

  • binder system
  • carboxyl-terminated polybutadiene
  • cure accelerator
  • mechanical properties

Fingerprint

Dive into the research topics of 'Improving Mechanical Properties of Carboxyl-Terminated Polybutadiene (CTPB) Binder System Using a Cure Accelerator'. Together they form a unique fingerprint.

Cite this